Form 4: Axogen Director William P. Burke Reports Acquisition of Shares and Stock Options

Director William P. Burke reports acquisition of Axogen shares and stock options as part of an annual equity grant.

Summary

• On June 6, 2024, William P. Burke, a director of Axogen, Inc., reported the acquisition of 10,653 shares of common stock.
• These shares were received as restricted stock units, each representing a contingent right to receive one share of Axogen common stock.
• Burke also acquired 18,248 employee stock options with an exercise price of $7.04.
• These options are part of an annual equity grant for service as a Director on the Axogen, Inc. Board of Directors and will vest on June 6, 2025.
• The equity grant is valued at $150,000 as of the grant date, with half in stock options and half in restricted stock units.
• Following these transactions, Burke beneficially owns 16,653 shares of common stock and 18,248 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard equity grant to a director. It doesn't contain any particularly positive or negative news.

Positives

• The acquisition of shares and stock options by a director signals confidence in the company's future.
• The equity grant incentivizes the director to contribute to the company's long-term success.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.

Stakeholder Impact

• The acquisition of shares and stock options by a director can positively influence shareholder confidence.
• The equity grant aligns the director's interests with those of the shareholders.

Key Dates